Gilead Sciences
Patents, Design & Utilities
Last updated:
List of all Gilead Sciences patents 302 in total
| Status | Patent |
|---|---|
Application | Utility: PHOSPHOLIPID COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: TOLL LIKE RECEPTOR MODULATOR COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Therapeutic compounds Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Choline salt forms of an HIV capsid inhibitor Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Methods for treating Filoviridae virus infections Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Solid forms of an HIV capsid inhibitor Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Methods of treating feline coronavirus infections Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Processes for preparing ASK1 inhibitors Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Metabolites of bictegravir Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: FLT3L-Fc FUSION PROTEINS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 17 Feb 2022 |
Grant | Utility: FXR (NR1H4) modulating compounds Filling date: 6 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: PD-1/PD-L1 inhibitors Filling date: 6 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: FXR (NR1H4) modulating compounds Filling date: 6 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Compounds for inhibition of alpha 4 beta 7 integrin Filling date: 6 Sep 2025 Issue date: 18 Jan 2022 |
Application | Utility: SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR Filling date: 6 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS Filling date: 6 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Utility: Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections Filling date: 6 Sep 2025 Issue date: 4 Jan 2022 |
Application | Utility: PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1`-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS Filling date: 6 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: REMDESIVIR TREATMENT METHODS Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: INTEGRASE INHIBITORS FOR THE PREVENTION OF HIV Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13- ,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-1- 0-carboxamide Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Substituted 6-azabenzimidazole compounds Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: LPA RECEPTOR ANTAGONISTS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Compounds for inhibition of .alpha.4.beta.7 integrin Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Imidazopyrimidine derivatives Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Imidazopyridine derivatives Filling date: 6 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Antibodies that target HIV GP120 and methods of use Filling date: 6 Sep 2025 Issue date: 9 Nov 2021 |
Application | Utility: NON-CODING IMMUNOMODULATORY DNA CONSTRUCT Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: INHALATION FORMULATIONS OF 1'-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS Filling date: 6 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: PD-1/PD-L1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: SOLID FORMS OF A COT INHIBITOR COMPOUND Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: COMBINATION THERAPY COMPRISING AN ACC INHIBITOR Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHODS OF PREPARING 1'-CYANO NUCLEOSIDES Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: ANTIVIRAL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: DEUTERATED TOLL-LIKE RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Grant | Utility: FLT3L-FC fusion proteins Filling date: 6 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Toll like receptor modulator compounds Filling date: 6 Sep 2025 Issue date: 21 Sep 2021 |
Application | Utility: TETRACYCLIC COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIVIRAL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIVIRAL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: METHODS FOR TREATING SARS COV-2 INFECTIONS Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Grant | Utility: Methods and intermediates for preparing therapeutic compounds Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Quinoline derivatives Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Modulators of toll-like receptors for the treatment of HIV Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Application | Utility: 4,6-DI- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Showing 50 to 100 of 302 patents.